0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cellular Therapy (CT) Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-24K13295
Home | Market Reports | Health| Pharmacy
Global Cellular Therapy CT Market Research Report 2023
BUY CHAPTERS

Global Cellular Therapy (CT) Market Research Report 2024

Code: QYRE-Auto-24K13295
Report
January 2024
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cellular Therapy (CT) Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Cellular Therapy (CT) Market

Cellular Therapy (CT) Market

Cellular therapy (CT) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.
The global Cellular Therapy (CT) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cellular Therapy (CT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cellular Therapy (CT).

Report Scope

The Cellular Therapy (CT) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cellular Therapy (CT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cellular Therapy (CT) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cellular Therapy (CT) Market Report

Report Metric Details
Report Name Cellular Therapy (CT) Market
CAGR 5%
Segment by Type
  • Stem Cell
  • Non-Stem Cell
Segment by Application
  • Hospitals
  • Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Gilead Sciences, Novartis, Osiris, Vericel Corporation, Vcanbio, Fujifilm Cellular Dynamics, JCR Pharmaceuticals, Beike Biotechnology, Golden Meditech, Guanhao Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cellular Therapy (CT) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cellular Therapy (CT) Market report?

Ans: The main players in the Cellular Therapy (CT) Market are Gilead Sciences, Novartis, Osiris, Vericel Corporation, Vcanbio, Fujifilm Cellular Dynamics, JCR Pharmaceuticals, Beike Biotechnology, Golden Meditech, Guanhao Biotech

What are the Application segmentation covered in the Cellular Therapy (CT) Market report?

Ans: The Applications covered in the Cellular Therapy (CT) Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Cellular Therapy (CT) Market report?

Ans: The Types covered in the Cellular Therapy (CT) Market report are Stem Cell, Non-Stem Cell

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cellular Therapy (CT) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Stem Cell
1.2.3 Non-Stem Cell
1.3 Market by Application
1.3.1 Global Cellular Therapy (CT) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cellular Therapy (CT) Market Perspective (2019-2030)
2.2 Cellular Therapy (CT) Growth Trends by Region
2.2.1 Global Cellular Therapy (CT) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cellular Therapy (CT) Historic Market Size by Region (2019-2024)
2.2.3 Cellular Therapy (CT) Forecasted Market Size by Region (2025-2030)
2.3 Cellular Therapy (CT) Market Dynamics
2.3.1 Cellular Therapy (CT) Industry Trends
2.3.2 Cellular Therapy (CT) Market Drivers
2.3.3 Cellular Therapy (CT) Market Challenges
2.3.4 Cellular Therapy (CT) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cellular Therapy (CT) Players by Revenue
3.1.1 Global Top Cellular Therapy (CT) Players by Revenue (2019-2024)
3.1.2 Global Cellular Therapy (CT) Revenue Market Share by Players (2019-2024)
3.2 Global Cellular Therapy (CT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cellular Therapy (CT) Revenue
3.4 Global Cellular Therapy (CT) Market Concentration Ratio
3.4.1 Global Cellular Therapy (CT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cellular Therapy (CT) Revenue in 2023
3.5 Cellular Therapy (CT) Key Players Head office and Area Served
3.6 Key Players Cellular Therapy (CT) Product Solution and Service
3.7 Date of Enter into Cellular Therapy (CT) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cellular Therapy (CT) Breakdown Data by Type
4.1 Global Cellular Therapy (CT) Historic Market Size by Type (2019-2024)
4.2 Global Cellular Therapy (CT) Forecasted Market Size by Type (2025-2030)
5 Cellular Therapy (CT) Breakdown Data by Application
5.1 Global Cellular Therapy (CT) Historic Market Size by Application (2019-2024)
5.2 Global Cellular Therapy (CT) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cellular Therapy (CT) Market Size (2019-2030)
6.2 North America Cellular Therapy (CT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cellular Therapy (CT) Market Size by Country (2019-2024)
6.4 North America Cellular Therapy (CT) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cellular Therapy (CT) Market Size (2019-2030)
7.2 Europe Cellular Therapy (CT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cellular Therapy (CT) Market Size by Country (2019-2024)
7.4 Europe Cellular Therapy (CT) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cellular Therapy (CT) Market Size (2019-2030)
8.2 Asia-Pacific Cellular Therapy (CT) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cellular Therapy (CT) Market Size by Region (2019-2024)
8.4 Asia-Pacific Cellular Therapy (CT) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cellular Therapy (CT) Market Size (2019-2030)
9.2 Latin America Cellular Therapy (CT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cellular Therapy (CT) Market Size by Country (2019-2024)
9.4 Latin America Cellular Therapy (CT) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cellular Therapy (CT) Market Size (2019-2030)
10.2 Middle East & Africa Cellular Therapy (CT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cellular Therapy (CT) Market Size by Country (2019-2024)
10.4 Middle East & Africa Cellular Therapy (CT) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Detail
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Cellular Therapy (CT) Introduction
11.1.4 Gilead Sciences Revenue in Cellular Therapy (CT) Business (2019-2024)
11.1.5 Gilead Sciences Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Cellular Therapy (CT) Introduction
11.2.4 Novartis Revenue in Cellular Therapy (CT) Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Osiris
11.3.1 Osiris Company Detail
11.3.2 Osiris Business Overview
11.3.3 Osiris Cellular Therapy (CT) Introduction
11.3.4 Osiris Revenue in Cellular Therapy (CT) Business (2019-2024)
11.3.5 Osiris Recent Development
11.4 Vericel Corporation
11.4.1 Vericel Corporation Company Detail
11.4.2 Vericel Corporation Business Overview
11.4.3 Vericel Corporation Cellular Therapy (CT) Introduction
11.4.4 Vericel Corporation Revenue in Cellular Therapy (CT) Business (2019-2024)
11.4.5 Vericel Corporation Recent Development
11.5 Vcanbio
11.5.1 Vcanbio Company Detail
11.5.2 Vcanbio Business Overview
11.5.3 Vcanbio Cellular Therapy (CT) Introduction
11.5.4 Vcanbio Revenue in Cellular Therapy (CT) Business (2019-2024)
11.5.5 Vcanbio Recent Development
11.6 Fujifilm Cellular Dynamics
11.6.1 Fujifilm Cellular Dynamics Company Detail
11.6.2 Fujifilm Cellular Dynamics Business Overview
11.6.3 Fujifilm Cellular Dynamics Cellular Therapy (CT) Introduction
11.6.4 Fujifilm Cellular Dynamics Revenue in Cellular Therapy (CT) Business (2019-2024)
11.6.5 Fujifilm Cellular Dynamics Recent Development
11.7 JCR Pharmaceuticals
11.7.1 JCR Pharmaceuticals Company Detail
11.7.2 JCR Pharmaceuticals Business Overview
11.7.3 JCR Pharmaceuticals Cellular Therapy (CT) Introduction
11.7.4 JCR Pharmaceuticals Revenue in Cellular Therapy (CT) Business (2019-2024)
11.7.5 JCR Pharmaceuticals Recent Development
11.8 Beike Biotechnology
11.8.1 Beike Biotechnology Company Detail
11.8.2 Beike Biotechnology Business Overview
11.8.3 Beike Biotechnology Cellular Therapy (CT) Introduction
11.8.4 Beike Biotechnology Revenue in Cellular Therapy (CT) Business (2019-2024)
11.8.5 Beike Biotechnology Recent Development
11.9 Golden Meditech
11.9.1 Golden Meditech Company Detail
11.9.2 Golden Meditech Business Overview
11.9.3 Golden Meditech Cellular Therapy (CT) Introduction
11.9.4 Golden Meditech Revenue in Cellular Therapy (CT) Business (2019-2024)
11.9.5 Golden Meditech Recent Development
11.10 Guanhao Biotech
11.10.1 Guanhao Biotech Company Detail
11.10.2 Guanhao Biotech Business Overview
11.10.3 Guanhao Biotech Cellular Therapy (CT) Introduction
11.10.4 Guanhao Biotech Revenue in Cellular Therapy (CT) Business (2019-2024)
11.10.5 Guanhao Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Cellular Therapy (CT) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Stem Cell
    Table 3. Key Players of Non-Stem Cell
    Table 4. Global Cellular Therapy (CT) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Cellular Therapy (CT) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Cellular Therapy (CT) Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Cellular Therapy (CT) Market Share by Region (2019-2024)
    Table 8. Global Cellular Therapy (CT) Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Cellular Therapy (CT) Market Share by Region (2025-2030)
    Table 10. Cellular Therapy (CT) Market Trends
    Table 11. Cellular Therapy (CT) Market Drivers
    Table 12. Cellular Therapy (CT) Market Challenges
    Table 13. Cellular Therapy (CT) Market Restraints
    Table 14. Global Cellular Therapy (CT) Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Cellular Therapy (CT) Market Share by Players (2019-2024)
    Table 16. Global Top Cellular Therapy (CT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cellular Therapy (CT) as of 2023)
    Table 17. Ranking of Global Top Cellular Therapy (CT) Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by Cellular Therapy (CT) Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Cellular Therapy (CT) Product Solution and Service
    Table 21. Date of Enter into Cellular Therapy (CT) Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Cellular Therapy (CT) Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Cellular Therapy (CT) Revenue Market Share by Type (2019-2024)
    Table 25. Global Cellular Therapy (CT) Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Cellular Therapy (CT) Revenue Market Share by Type (2025-2030)
    Table 27. Global Cellular Therapy (CT) Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Cellular Therapy (CT) Revenue Market Share by Application (2019-2024)
    Table 29. Global Cellular Therapy (CT) Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Cellular Therapy (CT) Revenue Market Share by Application (2025-2030)
    Table 31. North America Cellular Therapy (CT) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America Cellular Therapy (CT) Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America Cellular Therapy (CT) Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe Cellular Therapy (CT) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe Cellular Therapy (CT) Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe Cellular Therapy (CT) Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific Cellular Therapy (CT) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific Cellular Therapy (CT) Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific Cellular Therapy (CT) Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Cellular Therapy (CT) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America Cellular Therapy (CT) Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America Cellular Therapy (CT) Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa Cellular Therapy (CT) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa Cellular Therapy (CT) Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa Cellular Therapy (CT) Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Gilead Sciences Company Detail
    Table 47. Gilead Sciences Business Overview
    Table 48. Gilead Sciences Cellular Therapy (CT) Product
    Table 49. Gilead Sciences Revenue in Cellular Therapy (CT) Business (2019-2024) & (US$ Million)
    Table 50. Gilead Sciences Recent Development
    Table 51. Novartis Company Detail
    Table 52. Novartis Business Overview
    Table 53. Novartis Cellular Therapy (CT) Product
    Table 54. Novartis Revenue in Cellular Therapy (CT) Business (2019-2024) & (US$ Million)
    Table 55. Novartis Recent Development
    Table 56. Osiris Company Detail
    Table 57. Osiris Business Overview
    Table 58. Osiris Cellular Therapy (CT) Product
    Table 59. Osiris Revenue in Cellular Therapy (CT) Business (2019-2024) & (US$ Million)
    Table 60. Osiris Recent Development
    Table 61. Vericel Corporation Company Detail
    Table 62. Vericel Corporation Business Overview
    Table 63. Vericel Corporation Cellular Therapy (CT) Product
    Table 64. Vericel Corporation Revenue in Cellular Therapy (CT) Business (2019-2024) & (US$ Million)
    Table 65. Vericel Corporation Recent Development
    Table 66. Vcanbio Company Detail
    Table 67. Vcanbio Business Overview
    Table 68. Vcanbio Cellular Therapy (CT) Product
    Table 69. Vcanbio Revenue in Cellular Therapy (CT) Business (2019-2024) & (US$ Million)
    Table 70. Vcanbio Recent Development
    Table 71. Fujifilm Cellular Dynamics Company Detail
    Table 72. Fujifilm Cellular Dynamics Business Overview
    Table 73. Fujifilm Cellular Dynamics Cellular Therapy (CT) Product
    Table 74. Fujifilm Cellular Dynamics Revenue in Cellular Therapy (CT) Business (2019-2024) & (US$ Million)
    Table 75. Fujifilm Cellular Dynamics Recent Development
    Table 76. JCR Pharmaceuticals Company Detail
    Table 77. JCR Pharmaceuticals Business Overview
    Table 78. JCR Pharmaceuticals Cellular Therapy (CT) Product
    Table 79. JCR Pharmaceuticals Revenue in Cellular Therapy (CT) Business (2019-2024) & (US$ Million)
    Table 80. JCR Pharmaceuticals Recent Development
    Table 81. Beike Biotechnology Company Detail
    Table 82. Beike Biotechnology Business Overview
    Table 83. Beike Biotechnology Cellular Therapy (CT) Product
    Table 84. Beike Biotechnology Revenue in Cellular Therapy (CT) Business (2019-2024) & (US$ Million)
    Table 85. Beike Biotechnology Recent Development
    Table 86. Golden Meditech Company Detail
    Table 87. Golden Meditech Business Overview
    Table 88. Golden Meditech Cellular Therapy (CT) Product
    Table 89. Golden Meditech Revenue in Cellular Therapy (CT) Business (2019-2024) & (US$ Million)
    Table 90. Golden Meditech Recent Development
    Table 91. Guanhao Biotech Company Detail
    Table 92. Guanhao Biotech Business Overview
    Table 93. Guanhao Biotech Cellular Therapy (CT) Product
    Table 94. Guanhao Biotech Revenue in Cellular Therapy (CT) Business (2019-2024) & (US$ Million)
    Table 95. Guanhao Biotech Recent Development
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cellular Therapy (CT) Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Cellular Therapy (CT) Market Share by Type: 2023 VS 2030
    Figure 3. Stem Cell Features
    Figure 4. Non-Stem Cell Features
    Figure 5. Global Cellular Therapy (CT) Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 6. Global Cellular Therapy (CT) Market Share by Application: 2023 VS 2030
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Others Case Studies
    Figure 10. Cellular Therapy (CT) Report Years Considered
    Figure 11. Global Cellular Therapy (CT) Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Cellular Therapy (CT) Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Cellular Therapy (CT) Market Share by Region: 2023 VS 2030
    Figure 14. Global Cellular Therapy (CT) Market Share by Players in 2023
    Figure 15. Global Top Cellular Therapy (CT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cellular Therapy (CT) as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Cellular Therapy (CT) Revenue in 2023
    Figure 17. North America Cellular Therapy (CT) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Cellular Therapy (CT) Market Share by Country (2019-2030)
    Figure 19. United States Cellular Therapy (CT) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. Canada Cellular Therapy (CT) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Europe Cellular Therapy (CT) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Cellular Therapy (CT) Market Share by Country (2019-2030)
    Figure 23. Germany Cellular Therapy (CT) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. France Cellular Therapy (CT) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. U.K. Cellular Therapy (CT) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Italy Cellular Therapy (CT) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Russia Cellular Therapy (CT) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Nordic Countries Cellular Therapy (CT) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Asia-Pacific Cellular Therapy (CT) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Cellular Therapy (CT) Market Share by Region (2019-2030)
    Figure 31. China Cellular Therapy (CT) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Japan Cellular Therapy (CT) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. South Korea Cellular Therapy (CT) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Southeast Asia Cellular Therapy (CT) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. India Cellular Therapy (CT) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Australia Cellular Therapy (CT) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Latin America Cellular Therapy (CT) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Cellular Therapy (CT) Market Share by Country (2019-2030)
    Figure 39. Mexico Cellular Therapy (CT) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Brazil Cellular Therapy (CT) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa Cellular Therapy (CT) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Cellular Therapy (CT) Market Share by Country (2019-2030)
    Figure 43. Turkey Cellular Therapy (CT) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Saudi Arabia Cellular Therapy (CT) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Gilead Sciences Revenue Growth Rate in Cellular Therapy (CT) Business (2019-2024)
    Figure 46. Novartis Revenue Growth Rate in Cellular Therapy (CT) Business (2019-2024)
    Figure 47. Osiris Revenue Growth Rate in Cellular Therapy (CT) Business (2019-2024)
    Figure 48. Vericel Corporation Revenue Growth Rate in Cellular Therapy (CT) Business (2019-2024)
    Figure 49. Vcanbio Revenue Growth Rate in Cellular Therapy (CT) Business (2019-2024)
    Figure 50. Fujifilm Cellular Dynamics Revenue Growth Rate in Cellular Therapy (CT) Business (2019-2024)
    Figure 51. JCR Pharmaceuticals Revenue Growth Rate in Cellular Therapy (CT) Business (2019-2024)
    Figure 52. Beike Biotechnology Revenue Growth Rate in Cellular Therapy (CT) Business (2019-2024)
    Figure 53. Golden Meditech Revenue Growth Rate in Cellular Therapy (CT) Business (2019-2024)
    Figure 54. Guanhao Biotech Revenue Growth Rate in Cellular Therapy (CT) Business (2019-2024)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global OTC Scar Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-13J12359
Thu Jun 20 00:00:00 UTC 2024

Add to Cart

Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-26X10925
Wed Jun 19 00:00:00 UTC 2024

Add to Cart

Global Isosorbide Mononitrate Injection Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-15R11188
Wed Jun 19 00:00:00 UTC 2024

Add to Cart

Global Ambroxol Hydrochloride and Glucose Injection Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-10M10976
Wed Jun 19 00:00:00 UTC 2024

Add to Cart